Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
US6310040A · kind A · utility
18Cited by
4References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1992 |
| Grant date | Oct 30, 2001 |
| Priority date | — |
| Expiry date | Oct 15, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/839
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for promoting retinal neuronal survival in a mammal, wherein the neuronal cells are at risk of dying. The method comprises administering to the mammal an effective dose of at least one of the following substances: IGF-I; a functional derivative of IGF-I; IGF-II; or a functional derivative of IGF-II.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.